SFES — Safeguard Scientifics Cashflow Statement
0.000.00%
Last trade - 00:00- $16.37m
- $6.87m
- 32
- 49
- 77
- 52
Annual cashflow statement for Safeguard Scientifics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 54.6 | -37.6 | 27 | -14.3 | -9.83 |
| Depreciation | |||||
| Non-Cash Items | -71.2 | 29.7 | -31.9 | 11.9 | 6.49 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -4.17 | -0.214 | -3.28 | -0.908 | 0.032 |
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -20 | -8.14 | -8.15 | -3.26 | -3.31 |
| Other Investing Cash Flow Items | 126 | -1.27 | 58.1 | -4.66 | 5.72 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 126 | -1.27 | 58.1 | -4.66 | 5.72 |
| Financing Cash Flow Items | -0.236 | -0.04 | -0.144 | -0.549 | -0.358 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -89.5 | -0.04 | -40.8 | -3.49 | -6.25 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 16.9 | -9.45 | 9.16 | -11.4 | -3.84 |